Biotron Limited (BIT.AX)
Develops antiviral drugs to treat viruses like COVID-19, HIV, and hepatitis
0.00+0.25%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
BIT.AX is trading near its 52-week lows, about 17% up from the bottom of its recent range. The stock shows mixed momentum against its moving averages, and analyst sentiment leans bearish overall. Today's modest gain hasn't shifted the cautious near-term outlook.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Market cap
$7.0M
52-wk high
0.01
52-wk low
0.00
50-day avg
0.00
200-day avg
0.00
Trailing P/E
—